Applications, challenges, and outlook for PBPK modeling and simulation: a regulatory, industrial and academic perspective

W Lin, Y Chen, JD Unadkat, X Zhang, D Wu… - Pharmaceutical …, 2022 - Springer
Several regulatory guidances on the use of physiologically based pharmacokinetic (PBPK)
analyses and physiologically based biopharmaceutics model (s)(PBBM (s)) have been …

The role of uptake and efflux transporters in the disposition of glucuronide and sulfate conjugates

E Järvinen, F Deng, W Kiander, A Sinokki… - Frontiers in …, 2022 - frontiersin.org
Glucuronidation and sulfation are the most typical phase II metabolic reactions of drugs. The
resulting glucuronide and sulfate conjugates are generally considered inactive and safe …

Data-independent acquisition (DIA): an emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters

J Li, LS Smith, HJ Zhu - Drug Discovery Today: Technologies, 2021 - Elsevier
Data-independent acquisition (DIA) proteomics is a recently-developed global mass
spectrometry (MS)-based proteomics strategy. In a DIA method, precursor ions are isolated …

Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and …

JO Miners, TM Polasek, JA Hulin, A Rowland… - Pharmacology & …, 2023 - Elsevier
Drug-drug interactions (DDIs) arising from the perturbation of drug metabolising enzyme
activities represent both a clinical problem and a potential economic loss for the …

Quantitative investigation of irinotecan metabolism, transport, and gut microbiome activation

MM Parvez, A Basit, PB Jariwala, Z Gáborik… - Drug Metabolism and …, 2021 - ASPET
The anticancer drug irinotecan shows serious dose-limiting gastrointestinal toxicity
regardless of intravenous dosing. Although enzymes and transporters involved in irinotecan …

Co-Exposure of Phenanthrene and the cyp-Inducer 3-Methylchrysene Leads to Altered Biotransformation and Increased Toxicity in Fish Egg and Larvae

CE Donald, E Sørhus, P Perrichon… - Environmental …, 2023 - ACS Publications
Polycyclic aromatic hydrocarbons (PAHs) have frequently been suspected of governing
crude oil toxicity because of similar morphological defects in fish. However, PAH …

Cannabinoids and drug metabolizing enzymes: Potential for drug-drug interactions and implications for drug safety and efficacy

K Bardhi, S Coates, CJW Watson… - Expert Review of Clinical …, 2022 - Taylor & Francis
Introduction Cannabis is an increasingly popular recreational and medicinal drug in the
USA. While cannabis is still a Schedule 1 drug federally, many states have lifted the ban on …

Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism

A Isvoran, Y Peng, S Ceauranu, L Schmidt, AB Nicot… - Drug Discovery …, 2022 - Elsevier
Sulfotransferases (SULTs) are Phase II drug-metabolizing enzymes (DMEs) catalyzing the
sulfation of a variety of endogenous compounds, natural products, and drugs. Various drugs …

Inhibition of UDP-glucuronosyltransferase enzymes by major cannabinoids and their metabolites

S Nasrin, CJW Watson, K Bardhi, G Fort, G Chen… - Drug Metabolism and …, 2021 - ASPET
The UDP-glucuronosyltransferase (UGT) family of enzymes play a central role in the
metabolism and detoxification of a wide range of endogenous and exogenous compounds …

Human variability in carboxylesterases and carboxylesterase-related uncertainty factors for chemical risk assessment

E Di Consiglio, K Darney, FM Buratti, L Turco, S Vichi… - Toxicology Letters, 2021 - Elsevier
Carboxylesterases (CES) are an important class of enzymes involved in the hydrolysis of a
range of chemicals and show large inter-individual variability in vitro. An extensive literature …